Insight Molecular Diagnostics
(NASDAQ) IMDX
Insight Molecular Diagnostics Financials at a Glance
Market Cap
$114.44M
Revenue (TTM)
$4.05M
Net Income (TTM)
$50.22M
EPS (TTM)
$-1.62
P/E Ratio
-2.20
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Price
$2.55
Volume
265,030.406
Open
$3.48
Price
$2.55
Volume
265,030.406
Open
$3.48
Previous Close
$3.56
Daily Range
$2.52 - $3.66
52-Week Range
$2.33 - $8.51
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Price
$2.55
Volume
265,030.406
Open
$3.48
Previous Close
$3.56
Daily Range
$2.52 - $3.66
52-Week Range
$2.33 - $8.51
IMDX News
IMDX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Insight Molecular Diagnostics
Industry
Biotechnology
Sector
Health CareEmployees
58
CEO
Joshua Riggs
Website
www.oncocyte.comHeadquarters
Nashville, TN 92618, US
IMDX Financials
Key Financial Metrics (TTM)
Gross Margin
5%
Operating Margin
-8%
Net Income Margin
-12%
Return on Equity
-23603%
Return on Capital
-2%
Return on Assets
-2%
Earnings Yield
-45.45%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$114.44M
Shares Outstanding
32.15M
Volume
265.03K
Short Interest
0.00%
Avg. Volume
84.21K
Financials (TTM)
Gross Profit
$190.00K
Operating Income
$30.58M
EBITDA
$28.38M
Operating Cash Flow
$22.18M
Capital Expenditure
$3.19M
Free Cash Flow
$25.37M
Cash & ST Invst.
$11.58M
Total Debt
$3.50M
Insight Molecular Diagnostics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.14M
-23.4%
Gross Profit
$1.62M
-372.9%
Gross Margin
-1.43%
N/A
Market Cap
$114.44M
N/A
Market Cap/Employee
$2.49M
N/A
Employees
46
N/A
Net Income
$22.95M
+31.5%
EBITDA
$2.83M
+91.4%
Quarterly Fundamentals
Net Cash
$8.09M
+62.6%
Accounts Receivable
$1.13M
-30.1%
Inventory
$446.00K
+8.8%
Long Term Debt
$1.69M
-28.7%
Short Term Debt
$1.81M
+39.5%
Return on Assets
-1.95%
N/A
Return on Invested Capital
-2.24%
N/A
Free Cash Flow
$7.02M
-26.1%
Operating Cash Flow
$5.54M
-3.6%